Weekly cannabis briefing tracks Florida sales, M&A pressure and hemp deadlines

The Dales Report reviewed Florida medical cannabis sales, operator productivity, the widening buyer-target split under Schedule III and the November and December hemp deadlines. Oklahoma operators can use the cross-market comparison to benchmark retail productivity, watch consolidation pressure and separate immediate synthetic-cannabinoid exposure from the broader federal hemp deadline.